| Income Statement | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-09-30 |
|---|---|---|---|---|
| Total revenue | 17,631 | 15,009 | 13,139 | 14,629 |
| Cost of goods sold - (excluding amortization of acquired intangible assets) | 5,755 | 4,939 | 4,790 | - |
| Amortization of acquired intangible assets | 1,064 | 1,064 | 1,065 | - |
| Research and development | 287 | - | 39 | 842 |
| Cost of revenue | - | - | - | 5,285 |
| Selling, general and administrative | 12,054 | 11,882 | 10,569 | 11,396 |
| Total operating expenses | 19,160 | 17,885 | 16,463 | 17,523 |
| Loss from operations | -1,529 | -2,876 | -3,324 | -2,894 |
| Interest income | 154 | 138 | 149 | 188 |
| Gain (loss) on extinguishment of debt | - | - | - | 1,125 |
| Interest expense | 937 | 937 | 891 | 758 |
| Foreign exchange transaction losses | -3 | -61 | -7 | -51 |
| Total other expense (income) | -786 | -860 | -749 | 504 |
| Loss before income taxes | -2,315 | -3,736 | -4,073 | -2,390 |
| Income tax expense | - | 60 | - | - |
| Net loss | -2,315 | -3,796 | -4,073 | -2,390 |
| Earnings per share, basic | -0.09 | -0.16 | -0.18 | -0.12 |
| Earnings per share, diluted | -0.09 | -0.16 | -0.18 | -0.12 |
| Weighted average number of shares outstanding, basic | 24,959,114 | 23,290,806 | 22,611,040 | 20,537,794 |
| Weighted average number of shares outstanding, diluted | 24,959,114 | 23,290,806 | 22,611,040 | 20,537,794 |
Journey Medical Corp (DERM)
Journey Medical Corp (DERM)